Omeros Corp (GB:0KBU)
LSE:0KBU

Omeros (0KBU) Share Price & Analysis

0 Followers

0KBU Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.77 - $7.78
Previous Close$2.85
Volume2.34K
Average Volume (3M)3.80K
Market Cap
$183.54M
Enterprise Value$158.51M
Total Cash (Recent Filing)$341.28M
Total Debt (Recent Filing)$316.25M
Price to Earnings (P/E)N/A
Beta2.09
Nov 08, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding62,855,824
10 Day Avg. Volume118
30 Day Avg. Volume3,797
Standard Deviation0.21
R-Squared0.05
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)8.95
Price to Sales (P/S)3330.74
Price to Cash Flow (P/CF)-1.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue101.54
Enterprise Value/Gross Profit90.32
Enterprise Value/Ebitda-1.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0


Financials

Annual

0KBU FAQ

What was Omeros Corp’s price range in the past 12 months?
Omeros Corp lowest share price was $1.77 and its highest was $7.78 in the past 12 months.
    What is Omeros Corp’s market cap?
    Currently, no data Available
    When is Omeros Corp’s upcoming earnings report date?
    Omeros Corp’s upcoming earnings report date is Nov 08, 2023 which is in 35 days.
      How were Omeros Corp’s earnings last quarter?
      Omeros Corp released its earnings results on Aug 09, 2023. The company reported -$0.59 earnings per share for the quarter, missing the consensus estimate of -$0.57 by -$0.02.
        Is Omeros Corp overvalued?
        According to Wall Street analysts Omeros Corp’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Omeros Corp pay dividends?
          Omeros Corp does not currently pay dividends.
          What is Omeros Corp’s EPS estimate?
          Omeros Corp’s EPS estimate is -$0.62.
            How many shares outstanding does Omeros Corp have?
            Currently, no data Available
            What happened to Omeros Corp’s price movement after its last earnings report?
            Omeros Corp reported an EPS of -$0.59 in its last earnings report, missing expectations of -$0.57. Following the earnings report the stock price went down -3.325%.
              Which hedge fund is a major shareholder of Omeros Corp?
              Among the largest hedge funds holding Omeros Corp’s share is Sheaff Brock Investment Advisors LLC. It holds Omeros Corp’s shares valued at 327K.

                ---

                Omeros Stock Smart Score

                The Omeros Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Omeros Corp

                Omeros Corp. operates as a biopharmaceutical company. It engages in the discovery, development, and commercializes of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

                ---

                Forecast EPS vs Actual EPS


                Similar Stocks
                Company
                Price & Change
                Follow
                Omeros
                Cassava Sciences
                Akebia Therapeutics
                Kala Pharmaceuticals
                Aldeyra Therapeutics

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis